GlassScriptPhysician profile
Victor Mokarry
NPI 1144206129
$1,618.65
in general payments reported to CMS, 2019-2025
18 companies · $820 in 2025
The $820 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.18 · 2020: $61.32 · 2021: $40.77 · 2022: $99.94 · 2023: $171 · 2024: $403 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $486.35 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $371.93 | 2020-2025 | Dupixent |
| Glaxosmithkline, LLC. | $208.02 | 2024-2025 | Nucala |
| Stryker Corporation | $107.01 | 2020-2025 | Xpress Loprofile |
| Optinose US, INC. | $65.14 | 2023-2024 | |
| Harmony Biosciences LLC | $51.60 | 2025 | |
| Amgen INC. | $42.48 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $42.20 | 2023-2025 | Keytruda |
| Integra Lifesciences Corporation | $39.50 | 2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Aerin Medical INC. | $37.73 | 2024-2025 | |
| Inspire Medical Systems, INC. | $36.39 | 2023-2025 | Inspire |
| Medtronic USA, INC. | $22.18 | 2019 | |
| Smith+Nephew, INC. | $21.31 | 2023 | Coblation, Halo |
| Itamar Medical INC | $19.11 | 2022 | |
| Medtronic, INC. | $18.16 | 2025 | Stealthstation S8 Platform |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $18.15 | 2022 | |
| Axogen | $17.44 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $13.95 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Mokarry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.